e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular analysis of genes BMPR2 and KCNA5 in Spanish patients with pulmonary arterial hypertension
G. Pousada, A. Baloira, C. Vilariño, D. Valverde (Pontevedra, Vigo, Spain)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Session:
Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Session type:
Thematic Poster Session
Number:
957
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Pousada, A. Baloira, C. Vilariño, D. Valverde (Pontevedra, Vigo, Spain). Molecular analysis of genes BMPR2 and KCNA5 in Spanish patients with pulmonary arterial hypertension. Eur Respir J 2012; 40: Suppl. 56, 957
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Molecular characterization of the ACVRL1 and ENG genes in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Functional characterization of BMPR2 gene in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Functional analysis of the 5´UTR region of BMPR2 gene in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Analysis of the subcellular localization in BMPR2 gene in pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Screening of pulmonary arterial hypertension in BMPR2 mutation carriers
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients
Source: Eur Respir J 2012; 39: 597-603
Year: 2012
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation
Source: Eur Respir J 2012; 39: 1534-1535
Year: 2012
BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Phenotype and outcome of pulmonary arterial hypertension patients carrying a
TBX4
mutation
Source: Eur Respir J, 55 (5) 1902340; 10.1183/13993003.02340-2019
Year: 2020
Relationship of BMPR2 mutations and vasoreactivity in pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
Pulmonary arterial hypertension associated with several mutations
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Protein truncating mutations in ATP13A3 promote pulmonary arterial hypertension
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
Mutational and epigenetic analysis of the promoter region of
BMPR2
gene in patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Expression of fetal genes in pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation
Source: Eur Respir J 2007; 30: Suppl. 51, 250s
Year: 2007
Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 1195-1198
Year: 2014
A new molecular genetic diagnostic approach for pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept